Showing results (2071-2080 of 10,388) with videos related to

Sort By:
Pageof 1,039
Vaccines|February 24, 2024
Genital and Oral HPV Geno-Prevalence Measured through Urine and Saliva Samples in Young Adults in ItalyFrancesco Napolitano, Silvia Angelillo, Aida Bianco, et al.
Vaccines|February 24, 2024
Immune Evasion of SARS-CoV-2 Omicron Subvariants XBB.1.5, XBB.1.16 and EG.5.1 in a Cohort of Older Adults after ChAdOx1-S Vaccination and BA.4/5 Bivalent BoosterRafael Rahal Guaragna Machado, Érika Donizetti Candido, Andressa Simoes Aguiar, et al.
Vaccines|February 24, 2024
Vitamin D Supplementation and Prior Oral Poliovirus Vaccination Decrease Odds of COVID-19 Outcomes among Adults Recently Inoculated with Inactivated Poliovirus VaccineBrittany A Comunale, Yea-Jen Hsu, Robin J Larson, et al.
Vaccines|February 24, 2024
Spatial Analysis of Determinants of COVID-19 Vaccine Hesitancy in PortugalConstança Pinto de Carvalho, Manuel Ribeiro, Diogo Godinho Simões, et al.
Vaccines|February 24, 2024
The Dynamic Risk of COVID-19-Related Events in Vaccinated Healthcare Workers (HCWs) from a Tertiary Hospital in Bucharest, Romania: A Study Based on Active Surveillance DataCarmen-Daniela Chivu, Maria-Dorina Crăciun, Daniela Pițigoi, et al.
Vaccines|February 24, 2024
Effect of Platform Type on Clinical Efficacy of SARS-CoV-2 Vaccines in Prime Vaccination Settings: A Systematic Review and Meta-Regression of Randomized Controlled TrialsSergey Goryaynov, Olesya Gurova
Vaccines|February 24, 2024
The Live Attenuated Vaccine Strain "ARRIAH" Completely Protects Goats from a Virulent Lineage IV Field Strain of Peste Des Petits Ruminants VirusOlga Byadovskaya, Kseniya Shalina, Pavel Prutnikov, et al.
Vaccines|February 24, 2024
Quantitative Analysis of the Instant and Persistent Inhibition Effects of Maternal Poliovirus Antibodies on the Immune Response in a Phase IV Trial of a Sabin Strain-Based Inactivated Poliovirus VaccineQiongzhou Yin, Yan Zheng, Zhifang Ying, et al.
Vaccines|February 24, 2024
Persistence of Anti-SE36 Antibodies Induced by the Malaria Vaccine Candidate BK-SE36/CpG in 5-10-Year-Old Burkinabe Children Naturally Exposed to MalariaIssa Nebie, Nirianne Marie Q Palacpac, Edith Christiane Bougouma, et al.
Vaccines|February 24, 2024
The Impact of Clinical Factors and SARS-CoV-2 Variants on Antibody Production in Vaccinated German Healthcare Professionals Infected Either with the Delta or the Omicron VariantCatharina Gerhards, Marlene Steingass, Alexandra Heininger, et al.
Pageof 1,039